Back to Search
GEORGE WILDING, MD
MD
Medical Oncology Physician
NPI: 1235190141Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
29064(WI)
Research & Publications (20)
Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer.
PMID 16568471·Cancer·2006
3-trial
Phase I trial of the polyamine analog N1,N14-diethylhomospermine (DEHSPM) in patients with advanced solid tumors.
PMID 14739661·Invest New Drugs·2004
3-trial
Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen.
PMID 19540051·Int J Radiat Oncol Biol Phys·2010
8-other
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors.
PMID 19434370·Invest New Drugs·2010
3-trial
Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy.
PMID 19649630·Cancer Chemother Pharmacol·2010
8-other
Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
PMID 19649208·Neoplasia·2009
7-preclinical
Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation.
PMID 19418602·Clin Gastroenterol Hepatol·2009
4-observational
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study.
PMID 19347984·J Thorac Oncol·2009
3-trial
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
PMID 19487381·J Clin Oncol·2009
3-trial
Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy.
PMID 19549769·Clin Cancer Res·2009
4-observational
An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer.
PMID 19366825·Clin Cancer Res·2009
3-trial
Acute myeloid leukemia and diabetes insipidus with monosomy 7.
PMID 19380027·Cancer Genet Cytogenet·2009
5-case
Does the presence of significant risk factors affect perioperative outcomes after robot-assisted radical cystectomy?
PMID 19549262·BJU Int·2009
8-other
Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916.
PMID 19380444·J Clin Oncol·2009
3-trial
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.
PMID 19636017·J Clin Oncol·2009
3-trial
Estimation and prediction of renal function in patients with renal tumor.
PMID 19371883·J Urol·2009
8-other
Phase 2 trial of sorafenib in patients with advanced urothelial cancer: a trial of the Eastern Cooperative Oncology Group.
PMID 19536901·Cancer·2009
3-trial
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
PMID 19652060·J Clin Oncol·2009
3-trial
Current status of robot-assisted surgery in urology: a multi-national survey of 297 urologic surgeons.
PMID 19671225·Can J Urol·2009
8-other
Comparison of ACINUS, caspase-3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysis.
PMID 19644955·Prostate·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 HIGHLAND AVE
MADISON, WI 53792 - Phone
- (608) 265-1700
Quick Facts
- NPI
- 1235190141
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile